Winchester, CA, United States of America

William Hite

USPTO Granted Patents = 8 

 

Average Co-Inventor Count = 2.2

ph-index = 1


Company Filing History:


Years Active: 2023-2025

Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents

Title: The Innovative Contributions of William Hite

Introduction

William Hite is a notable inventor based in Winchester, California, with a remarkable portfolio of eight patents. His work primarily focuses on pharmaceutical formulations, showcasing his commitment to advancing medical science and improving patient care.

Latest Patents

Among his latest patents, Hite has developed aqueous formulations of topiramate. These formulations are designed to be storage-stable and suitable for oral administration, containing a therapeutically effective amount of topiramate, PEG 400, water, and glycerol. Additionally, they may include sweeteners and flavorants to enhance palatability. Another significant patent involves aqueous pharmaceutical compositions of prostaglandins, which are suitable for topical ophthalmic administration. These compositions aim to reduce intraocular pressure and promote eyelash growth without the addition of benzalkonium chloride.

Career Highlights

Hite has made significant contributions to the pharmaceutical industry through his work with companies such as Tap Pharmaceuticals and Famygen Life Sciences, Inc. His innovative spirit and dedication to research have led to advancements in drug formulations that benefit patients.

Collaborations

Throughout his career, Hite has collaborated with talented professionals, including Nilesh Parikh and Kartik Shah. These partnerships have fostered an environment of creativity and innovation, further enhancing the impact of his work.

Conclusion

William Hite's contributions to pharmaceutical innovations demonstrate his expertise and commitment to improving healthcare solutions. His patents reflect a deep understanding of the needs within the medical field, making him a valuable figure in the realm of invention.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…